3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation
Language English Country United States Media print-electronic
Document type Journal Article
PubMed
29855854
DOI
10.1007/s12223-018-0620-5
PII: 10.1007/s12223-018-0620-5
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents chemical synthesis pharmacology MeSH
- Biofilms drug effects MeSH
- Virulence Factors MeSH
- Metal Nanoparticles * MeSH
- Microbial Sensitivity Tests MeSH
- Microbial Viability drug effects MeSH
- Pseudomonas Infections metabolism microbiology MeSH
- Pseudomonas aeruginosa drug effects physiology MeSH
- Reactive Oxygen Species metabolism MeSH
- Silver * MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- Virulence Factors MeSH
- Reactive Oxygen Species MeSH
- Silver * MeSH
Microbial biofilms are factions of surface-colonized cells encompassed in a matrix of extracellular polymeric substances. Profound application of antibiotics in order to treat infections due to microbial biofilm has led to the emergence of several drug-resistant microbial strains. In this context, a novel type of 3,6-di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) was synthesized, and efforts were given to test its antimicrobial and antibiofilm activities against Pseudomonas aeruginosa, a widely used biofilm-forming pathogenic organism. The synthesized TzAgNPs showed considerable antimicrobial activity wherein the MIC value of TzAgNPs was found at 40 μg/mL against Pseudomonas aeruginosa. Antibiofilm activity of TzAgNPs was also tested against Pseudomonas aeruginosa by carrying out an array of experiments like microscopic observation, crystal violet assay, and protein count using the sub-MIC doses of TzAgNPs. Since TzAgNPs showed efficient antibiofilm activity, thus, in the present study, efforts were put together to investigate the underlying cause of biofilm attenuation of Pseudomonas aeruginosa by using TzAgNPs. To this end, we discerned that the sub-MIC doses of TzAgNPs increased ROS level considerably in the bacterial cell. The result showed that the ROS level and microbial biofilm formation are inversely proportional. Thus, the attenuation in microbial biofilm could be attributed to the accumulation of ROS level. Furthermore, it was also duly noted that microorganisms upon treatment with TzAgNPs exhibited considerable diminution in virulence factors (protease and pyocyanin) in contrast to the control where the organisms were not treated with TzAgNPs. Thus, the results indicated that TzAgNPs exhibit considerable reduction in the development of biofilms and spreading of virulence factors. Taken together, all the results indicated that TzAgNPs could be deemed to be a promising agent for the prevention of microbial biofilm development that might assist to fight against infections linked to biofilm.
Department of Biotechnology The Neotia University Sarisha West Bengal 743368 India
Department of Human Physiology Tripura University Suryamani Nagar Bikramnagar Tripura 799022 India
See more in PubMed
Antimicrob Agents Chemother. 2006 Apr;50(4):1463-9 PubMed
J Drug Deliv. 2012;2012:751075 PubMed
Biol Chem. 1997 Nov;378(11):1259-65 PubMed
Annu Rev Microbiol. 2003;57:395-418 PubMed
Curr Opin Microbiol. 2009 Oct;12(5):482-9 PubMed
Sci Rep. 2016 Mar 22;6:23347 PubMed
J Bacteriol. 1990 Feb;172(2):884-900 PubMed
Cell Microbiol. 2009 Jul;11(7):1034-43 PubMed
Arch Microbiol. 2016 Jan;198(1):1-15 PubMed
PLoS One. 2014 Nov 17;9(11):e111289 PubMed
Fitoterapia. 2013 Oct;90:73-8 PubMed
Clin Rev Allergy Immunol. 2008 Dec;35(3):124-34 PubMed
Antimicrob Agents Chemother. 2001 Apr;45(4):999-1007 PubMed
J Appl Microbiol. 2016 Apr;120(4):842-59 PubMed
Bioconjug Chem. 2011 Nov 16;22(11):2263-70 PubMed
Chem Biol. 2012 Dec 21;19(12):1503-13 PubMed
J Clin Microbiol. 1999 Jun;37(6):1771-6 PubMed
Chem Rev. 2010 Jun 9;110(6):3299-314 PubMed
Nature. 2001 Oct 25;413(6858):860-4 PubMed
J Am Coll Nutr. 2003 Feb;22(1):18-35 PubMed
Antonie Van Leeuwenhoek. 2018 Jan;111(1):89-99 PubMed
J Biol Chem. 1951 Nov;193(1):265-75 PubMed
ACS Nano. 2012 Sep 25;6(9):8316-24 PubMed
FEMS Microbiol Lett. 2013 Jan;338(2):177-83 PubMed